| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 22, 2020 | Tattory John A | SVP &CFO | Buy | 449 | $7.25 | $3,255.25 | +5.1% | |
| May 22, 2020 | Simonson Steven | SVP, Chief Medical Officer | Buy | 517 | $7.25 | $3,748.25 | +5.0% | |
| May 22, 2020 | Geffken Daniel E. | Director | Buy | 2,069 | $7.25 | $15,000.25 | New | |
| May 22, 2020 | Schreiber Brian D | Director | Buy | 2,069 | $7.25 | $15,000.25 | New | |
| May 22, 2020 | Fraser Craig | President And CEO | Buy | 2,069 | $7.25 | $15,000.25 | +9.6% | |
| May 22, 2020 | Peacock Bruce | Director | Buy | 3,500 | $7.25 | $25,375.00 | +65.0% | |
| May 22, 2020 | Joseph Mahady M | Director | Buy | 2,069 | $7.25 | $15,000.25 | +38.4% | |
| May 22, 2020 | Leone John R | Director | Buy | 2,069 | $7.25 | $15,000.25 | +38.3% | |
| May 22, 2020 | Huang James | Director, 10% Owner | Buy | 275,862 | $7.25 | $1,999,999.50 | +13.4% | |
| May 20, 2020 | Bioengine Capital Inc. | 10% Owner | Buy | 55,172 | $7.25 | $399,997.00 | +4.7% |